Tolerability, exposure and pharmacokinetics in healthy subjects of a Chinese herbal medicine MaZiRenWan (MZRW): Study protocol for a randomized open-labelled, three-arm phase 0/1 clinical trial

European Journal of Integrative Medicine

Volumn 8, Issue 4, 2016, Pages 581-586

  Zhong, Linda L D ^a   Kun, Wai ^a   Zhao, Ling ^a   Lin, Cheng Yuan ^a   Huang, Tao ^a   Bian, Zhao Xiang ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

Chinese herbal medicine; Constipation; MaZiRenWan; Pharmacokinetics; Phase 0 1 clinical trial; Safety

Indexed keywords

HERBACEOUS AGENT; MAZIRENWAN EXTRACT; UNCLASSIFIED DRUG;

AREA UNDER THE CURVE; ARTICLE; CHINESE HERB; CHINESE MEDICINE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; MAXIMUM PLASMA CONCENTRATION; OPEN STUDY; OUTCOME ASSESSMENT; PHARMACOKINETIC PARAMETERS; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 84962158432     PISSN: 18763820     EISSN: 18763839     Source Type: Journal    
DOI: 10.1016/j.eujim.2016.03.008     Document Type: Article

References (18)

1. [1] Eoff, J.C., Optimal treatment of chronic constipation in managed care: review and roundtable discussion. J. Manag. Care Pharm. 14 (2008), 1–15.
2. [2] Bharucha, A.E., Pemberton, J.H., Locke, G.R. III, American Gastroenterological Association technical review on constipation. Am. Gastroenterol. Assoc. Gastroenterol. 144 (2013), 218–238.
3. [3] Drossman, D.A., Corazziari, E., Delvaux, M., et al. Rome III: The Functional Gastrointestinal Disorders. third edition, 2006, Degnon Associates, McLean, VA.
4. [4] Ramkumar, D., Rao, S.S., Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. Am. J. Gastroenterol. 100 (2005), 936–971.
5. [5] Jiang, C., Xu, Q., Wen, X., Sun, H., Current developments in pharmacological therapeutics for chronic constipation. Acta Pharm. Sin. B 5:4 (2015), 300–309.
6. [6] Zhang, B.Y., Dong, J.H., Zhou, Z.Y., Traditional Chinese Internal Medicine. 1985, Shang Hai Science and Technology Press, Shang Hai.
7. [7] Maclean, W., Lyttleton, J., Clinical Handbook of Internal Medicine: The Treatment of Disease with Traditional Chinese Medicine. 2002, University of Western Sydney, Macarthur, Sydney.
8. [8] Peng, B., Fang, X., Wang, Y., Traditional Chinese Internal Medicine. 2nd ed., 2007, People's Medical Publishing House, Beijing.
9. [9] Bensky, D., Chinese Herbal Medicine: Formulas & Strategies. 1990, Eastland Press, Washington.
10. [10] Zhu, Y.P., Chinese Materia Medica: Chemistry, Pharmacology, and Applications. 1998, Harwood Academic Amsterdam, Netherlands.
11. [11] Li, X., Wei, W., Chinese Materia Medica: Combinations and Applications. 2002, Donica, St. Albans.
12. [12] Cheng, C.W., Bian, Z.X., Wu, T.X., Systematic review of Chinese herbal medicine for functional constipation. World J. Gastroenterol. 15 (2009), 4886–4895.
13. [13] Lai, T.S., Clinical Handbook of Chinese Herbal Formulae. 1996, People's Medical Publishing House, Beijing, China.
14. [14] Cheng, C.W., Bian, Z.X., Zhu, L.X., et al. Efficacy of a Chinese herbal proprietary medicine (Hemp Seed Pill) for functional constipation. Am. J. Gastroenterol. 106 (2011), 120–129.
15. [15] Bian, Z.X., Cheng, C.W., Zhu, L.Z., Chinese herbal medicine for functional constipation: a randomised controlled trial. Hong Kong Med. J. 19:Suppl. 9 (2013), 44–46.
16. [16] Kositchaiwat, S., Suwanthanmma, W., Suvikapakornkul, R., et al. Comparative study of two bowel preparation regimens for colonoscopy: senna tablets vs sodium phosphate solution. World J. Gastroenterol. 12 (2006), 5536–5539.
17. [17] Central Co-ordinating Committee (Medicine), Handbook of Internal Medicine. 2008, Hong Kong Hospital Authority, Hong Kong.
18. [18] Chinese Pharmacopoeia Commission, Pharmacopoeia of the People's Republic of China. 2005th ed., 2005, People's Medical Publishing House, Beijing, China.